Drug interactions between COPD and ibandronate
Interactions between your drugs
There were no interactions found in our database between COPD and ibandronate - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
A total of 80 drugs are known to interact with COPD.
- COPD is in the drug class antiasthmatic combinations.
- COPD is used to treat the following conditions:
- Ibandronate is a member of the drug class bisphosphonates.
- Ibandronate is used to treat the following conditions:
Drug and food interactions
Applies to: ibandronate
Food may reduce the absorption of ibandronate, which may lead to lower blood levels of the medication and possibly reduced effectiveness. You should take ibandronate first thing in the morning, at least 30 minutes before you eat or drink anything or take any other medication. Take each dose with a full glass (6 to 8 ounces) of water, and use only plain water (not mineral or vitamin water). Do not take ibandronate if you cannot sit upright or stand for at least 30 minutes. Because ibandronate can cause irritation and ulcer in the stomach or esophagus (the tube that connects your mouth and stomach), you will need to stay upright for at least 30 minutes after taking this medication. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.